<p>加利福尼亞州諾瓦託 --（商業資訊）--QT Imaging Holdings, Inc.（OTCQB: QTIH）（“QT Imaging” 或 “公司”）是一家致力於通過創新的無輻射成像技術轉變乳腺健康管理的醫療設備公司，今天宣佈已獲得批准，將其普通股從 OTCQB 風險市場提升至納斯達克資本市場。預計該公司的股票將於 2026 年 1 月 28 日星期三在納斯達克證券市場（“納斯達克”）以 “QTI” 作為股票代碼開始交易。</p>
<p>QT Imaging 首席執行官 Raluca Dinu 博士表示：“我們非常高興獲得重新在納斯達克資本市場上市的批准。這一里程碑代表了我們不懈努力扭轉公司局面、重建商業模式、資產負債表和股本結構，重建信任，並重新聚焦於真正重要的事情。我們的團隊在不確定性中以紀律、韌性和信念堅持下去，得到了始終支持我們的股東的支持。我們在被摘牌不到一年後重新回到了納斯達克。</p>
<p>QT Imaging 的存在是出於一個簡單而深刻的個人原因。女性應當擁有更好的乳腺成像選擇、更早的答案，以及將她們的安全和尊嚴放在首位的護理。我們所做的一切都是為了將這項技術從實驗室帶到臨牀醫生和她們所服務的女性手中。作為一家使命明確的更強大公司，我們相信納斯達克上市將提高我們的知名度，擴大我們的股東基礎，並支持長期價值創造。我們為自己走過的路感到自豪，並對未來充滿活力。</p>
<p>QT Imaging 滿足了所有納斯達克資本市場的上市要求，包括財務、公司治理和監管標準。此次提升與公司的長期戰略願景相一致，即擴大其全球足跡並推動公司邁向技術進步的未來。</p>
<p>QT Imaging 仍然致力於通過創新、卓越運營和有序增長為股東提供持續價值。投資者可以期待在公司開啓這一激動人心的新篇章時獲得進一步的更新。</p>
<p><strong>關於 QT Imaging Holdings, Inc.</strong></p>
<p>QT Imaging Holdings, Inc.是一家公開的醫療設備公司，專注於使用低頻聲波進行創新體成像系統的研究、開發和商業化。QT Imaging Holdings, Inc.努力改善全球健康結果。其戰略基於醫療成像對疾病的檢測、診斷和治療至關重要，並且應該是安全、可負擔、可獲得，並以患者體驗為中心。有關 QT Imaging Holdings, Inc.的更多信息，請訪問公司網站 www.qtimaging.com。</p>
<p>Breast Acoustic CT™是 QT Imaging Holdings, Inc.的一個關聯公司的商標。</p>
<p><strong>前瞻性聲明</strong></p>
<p>本新聞稿包含根據 1933 年證券法第 27A 條及 1934 年證券交易法第 21E 條的修訂版的前瞻性聲明。這些聲明包含 “將” 和 “預計” 等詞語，或其否定形式或類似術語，包括（但不限於）關於提升至納斯達克資本市場的聲明、QT Imaging 的計劃、新產品開發和推出、產品銷售增長和預計收入的聲明。前瞻性聲明涉及某些風險和不確定性，實際結果可能與任何此類聲明中討論的結果有重大差異。這些風險包括但不限於：公司提升至納斯達克資本市場的能力，包括滿足初始和持續上市要求；使用 QTI Breast Acoustic CT 掃描儀的研究結果、臨牀研究、QT Imaging 銷售和部署 QTI Breast Acoustic CT 掃描儀的能力、將產品擴展到新領域或產品的能力、商業化技術的能力、阻礙產品全面文檔和 “推向市場” 計劃的意外事件、行業趨勢和波動、客户需求和採購量的變化、供應商的不可預測性、吸引和留住合格人員的能力以及將產品銷售提升至生產水平的能力。可能導致實際結果有所不同的其他因素在 QT Imaging Holdings 向 SEC 提交的文件以及其不時提交或提供的其他當前和定期報告的 “風險因素” 標題下和其他部分中進行了討論。本新聞稿中的所有前瞻性聲明均基於 QT Imaging Holdings 截至本日期的信息，QT Imaging Holdings 不承擔更新任何前瞻性聲明的義務。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMjc1NDk4ODZyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMjc1NDk4ODZyMQ"/></p>
<p>查看商業資訊上的源版本：https://www.businesswire.com/news/home/20260127549886/en/</p>
<p><strong>媒體諮詢，請聯繫：</strong></p>
<p><strong>Stephen Kilmer</strong></p>
<p>投資者關係負責人</p>
<p>Stephen.Kilmer@qtimaging.com</p>
<p>電話： (646) 274-3580</p>
<p>來源：QT Imaging Holdings, Inc.</p>

<p>QT Imaging Holdings, Inc. 宣佈將從 OTCQB 風險市場升級至納斯達克資本市場，預計將於 2026 年 1 月 28 日以 "QTI" 的股票代碼開始交易。首席執行官 Dr. Raluca Dinu 表示對公司扭轉局勢的努力感到自豪，並承諾通過創新的成像技術改善乳腺健康管理。此次升級與 QT Imaging 的戰略願景相一致，旨在實現增長和提高知名度，增強股東價值並擴大其全球影響力</p>

<p>NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it has received approval to uplist its common stock from the OTCQB Venture Market to the Nasdaq Capital Market. The Company’s shares are expected to commence trading on Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “QTI” tomorrow Wednesday, January 28, 2026.</p>
<div class="lb-trans"><p>加利福尼亞州諾瓦託 --（商業資訊）--QT Imaging Holdings, Inc.（OTCQB: QTIH）（“QT Imaging” 或 “公司”）是一家致力於通過創新的無輻射成像技術轉變乳腺健康管理的醫療設備公司，今天宣佈已獲得批准，將其普通股從 OTCQB 風險市場提升至納斯達克資本市場。預計該公司的股票將於 2026 年 1 月 28 日星期三在納斯達克證券市場（“納斯達克”）以 “QTI” 作為股票代碼開始交易。</p>
</div><p>“We are very pleased to have received approval to reestablish our listing on the Nasdaq Capital Market,” said QT Imaging Chief Executive Officer Dr. Raluca Dinu. “This milestone represents relentless work to turn the company around, rebuild its business model, its balance sheet, cap table, rebuild the trust, and refocus on what truly matters. Our team pushed through uncertainty with discipline, resilience, and belief, supported every step of the way by stockholders who stayed with us. We returned to Nasdaq after less than one year of being delisted.</p>
<div class="lb-trans"><p>QT Imaging 首席執行官 Raluca Dinu 博士表示：“我們非常高興獲得重新在納斯達克資本市場上市的批准。這一里程碑代表了我們不懈努力扭轉公司局面、重建商業模式、資產負債表和股本結構，重建信任，並重新聚焦於真正重要的事情。我們的團隊在不確定性中以紀律、韌性和信念堅持下去，得到了始終支持我們的股東的支持。我們在被摘牌不到一年後重新回到了納斯達克。</p>
</div><p>“QT Imaging exists for a simple and deeply personal reason. Women deserve better options for breast imaging, earlier answers, and care that puts their safety and dignity first. Everything we have done has been in service of bringing this technology out of the lab and into the hands of clinicians and the women they serve. As a stronger company with a clear mission, we believe a Nasdaq listing increases our visibility, expands our stockholder base, and supports long term value creation. We are proud of how far we have come and energized by what lies ahead.”</p>
<div class="lb-trans"><p>QT Imaging 的存在是出於一個簡單而深刻的個人原因。女性應當擁有更好的乳腺成像選擇、更早的答案，以及將她們的安全和尊嚴放在首位的護理。我們所做的一切都是為了將這項技術從實驗室帶到臨牀醫生和她們所服務的女性手中。作為一家使命明確的更強大公司，我們相信納斯達克上市將提高我們的知名度，擴大我們的股東基礎，並支持長期價值創造。我們為自己走過的路感到自豪，並對未來充滿活力。</p>
</div><p>QT Imaging met all Nasdaq Capital Market listing requirements, including financial, corporate governance, and regulatory criteria. The uplisting aligns with the Company’s long-term strategic vision of expanding its global footprint and advancing the Company into the future of technological advances.</p>
<div class="lb-trans"><p>QT Imaging 滿足了所有納斯達克資本市場的上市要求，包括財務、公司治理和監管標準。此次提升與公司的長期戰略願景相一致，即擴大其全球足跡並推動公司邁向技術進步的未來。</p>
</div><p>QT Imaging remains committed to delivering sustained value to its shareholders through innovation, operational excellence, and disciplined growth. Investors can look forward to further updates as the Company embarks on this exciting new chapter.</p>
<div class="lb-trans"><p>QT Imaging 仍然致力於通過創新、卓越運營和有序增長為股東提供持續價值。投資者可以期待在公司開啓這一激動人心的新篇章時獲得進一步的更新。</p>
</div><p><strong>About QT Imaging Holdings, Inc.</strong></p>
<div class="lb-trans"><p><strong>關於 QT Imaging Holdings, Inc.</strong></p>
</div><p>QT Imaging Holdings, Inc. is a public medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com.</p>
<div class="lb-trans"><p>QT Imaging Holdings, Inc.是一家公開的醫療設備公司，專注於使用低頻聲波進行創新體成像系統的研究、開發和商業化。QT Imaging Holdings, Inc.努力改善全球健康結果。其戰略基於醫療成像對疾病的檢測、診斷和治療至關重要，並且應該是安全、可負擔、可獲得，並以患者體驗為中心。有關 QT Imaging Holdings, Inc.的更多信息，請訪問公司網站 www.qtimaging.com。</p>
</div><p>Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.</p>
<div class="lb-trans"><p>Breast Acoustic CT™是 QT Imaging Holdings, Inc.的一個關聯公司的商標。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the uplisting to the Nasdaq Capital Market, plans for QT Imaging, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: the Company’s ability to uplist to the Nasdaq Capital Market, including meeting the initial and continuous listing requirements; research results from the use of the QTI Breast Acoustic CT scanner, clinical studies, the ability of QT Imaging to sell and deploy the QTI Breast Acoustic CT scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.</p>
<div class="lb-trans"><p>本新聞稿包含根據 1933 年證券法第 27A 條及 1934 年證券交易法第 21E 條的修訂版的前瞻性聲明。這些聲明包含 “將” 和 “預計” 等詞語，或其否定形式或類似術語，包括（但不限於）關於提升至納斯達克資本市場的聲明、QT Imaging 的計劃、新產品開發和推出、產品銷售增長和預計收入的聲明。前瞻性聲明涉及某些風險和不確定性，實際結果可能與任何此類聲明中討論的結果有重大差異。這些風險包括但不限於：公司提升至納斯達克資本市場的能力，包括滿足初始和持續上市要求；使用 QTI Breast Acoustic CT 掃描儀的研究結果、臨牀研究、QT Imaging 銷售和部署 QTI Breast Acoustic CT 掃描儀的能力、將產品擴展到新領域或產品的能力、商業化技術的能力、阻礙產品全面文檔和 “推向市場” 計劃的意外事件、行業趨勢和波動、客户需求和採購量的變化、供應商的不可預測性、吸引和留住合格人員的能力以及將產品銷售提升至生產水平的能力。可能導致實際結果有所不同的其他因素在 QT Imaging Holdings 向 SEC 提交的文件以及其不時提交或提供的其他當前和定期報告的 “風險因素” 標題下和其他部分中進行了討論。本新聞稿中的所有前瞻性聲明均基於 QT Imaging Holdings 截至本日期的信息，QT Imaging Holdings 不承擔更新任何前瞻性聲明的義務。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjAxMjc1NDk4ODZyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260127549886r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20260127549886/en/</p>
<div class="lb-trans"><p>查看商業資訊上的源版本：https://www.businesswire.com/news/home/20260127549886/en/</p>
</div><p><strong>For media inquiries, please contact:</strong></p>
<div class="lb-trans"><p><strong>媒體諮詢，請聯繫：</strong></p>
</div><p><strong>Stephen Kilmer</strong></p>
<div class="lb-trans"><p><strong>Stephen Kilmer</strong></p>
</div><p>Head of Investor Relations</p>
<div class="lb-trans"><p>投資者關係負責人</p>
</div><p>Stephen.Kilmer@qtimaging.com</p>
<div class="lb-trans"><p>Stephen.Kilmer@qtimaging.com</p>
</div><p>Direct: (646) 274-3580</p>
<div class="lb-trans"><p>電話： (646) 274-3580</p>
</div><p>Source: QT Imaging Holdings, Inc.</p>
<div class="lb-trans"><p>來源：QT Imaging Holdings, Inc.</p>
</div>

QT Imaging 宣佈在納斯達克市場升級上市 | QTIH 股票新聞